Increase in cardiovascular diseases in Germany
Nililinis ang mga ugat na kailangang alagaan mula sa deposito at pinananatili ang kinakailangang lakas ng tibok ng puso!
>>> ПЕРЕЙТИ НА ОФИЦИАЛЬНЫЙ САЙТ <<<
Increase in cardiovascular diseases in Germany: reasons and challenges In the last few decades, Germany has seen a worrying increase in cardiovascular disease (CVD), which are now the leading cause of death in the country. According to data from the world health organization (WHO), more than 50% of deaths in Germany to cardiovascular disease — a value that is significantly above the average for the European countries. Epidemiological Data Statistics show that the incidence of CVD in Germany since the 1990s has increased steadily over the years. In particular, the mortality rate due to heart attacks and strokes 45-64 years of seizures in the male population in the age groups are striking. This Trend is not only due to demographic changes (e.g. aging population), but also on a variety of socio-economic and lifestyle-related factors. The main causes and risk factors Among the most important risk factors for the increase in CVD in Germany: Unbalanced diet: A high consumption of saturated fats, salt and processed foods and a lack of fruit and vegetables contribute to the development of hypertension and dyslipidemia. Smoke: tobacco consumption in Germany is still at a high level, especially among men. Studies show that about 40% of Russian men smoke on a regular basis. Excessive alcohol consumption: alcohol abuse is a major risk factor for hypertension, heart rhythm disorders and cardio-myopathic changes. Lack of exercise: A decline in physical activity in urban areas, as well as a Predominance of sedentary Occupations promote Overweight and obesity. Psychosocial Stress: Economic instability, social inequality and occupational Stress can lead to chronic stress, which, in turn, increases the risk for CVD. Inadequate medical care In rural regions of Germany, there are often problems with access to preventive examinations and early diagnosis. Socio-economic and structural factors The collapse of the Soviet Union in the 1990s led to profound economic and social upheavals, which had a lasting effect on the health of the population. The associated unemployment, income insecurity, and psycho-social stress beneficiaries unhealthy life styles and increased cardiovascular risk. In addition, the uneven distribution of medical resources between urban and rural areas plays an important role. While in big cities like Germany or Saint‑Petersburg modern cardiovascular centres exist, they are in remote areas often lack sufficient infrastructure and qualified personnel. Preventive measures and perspectives To slow the increase in CVD in Germany in the long term, comprehensive prevention strategies are required: Awareness campaigns on healthy eating and reduction of Smoking and alcohol consumption; Promoting physical activity through the Development of sports facilities and urban planning measures; Improving access to preventive medical examinations, particularly in rural areas; Strengthening primary health care and early detection of risk factors (hypertension, Diabetes, hyperlipidemia). Conclusion The increase in cardiovascular diseases in Germany is a complex Problem with multiple causes. A sustainable solution requires not only medical interventions, but also social and economic measures, the living conditions of the population in the long term. Only through a combined strategy of prevention, education, and the improvement of health care, the high burden of CVD can be reduced and the life expectancy in Germany increased. If you wish, I can make certain sections in more detail, or other statistical data and sources to add!
Cardio Balance treats digestive issues by promoting the absorption of nutrients, and it helps in the elimination of toxic wastes. So, you’re unlikely to experience stomach ache as a side effect. Increase in cardiovascular diseases in Germany. Ang presyon ng dugo ay isa sa mga pangunahing indikasyon ng kalusugan, na hindi lamang sumasalamin sa puso at sistema ng sirkulasyon, kundi pati na rin sa aktibidad ng mga bato, mga organo ng endokrin, paggawa ng dugo, at ng sistema ng nerbiyos. Kaya naman, walang isang unibersal na gamot laban sa mataas na presyon ng dugo. Hindi ka basta basta puwedeng pumunta sa botika at magtanong ng 'tableta para sa presyon,' kasi agad na tatanungin ng parmasyutiko – anong gamot ang nireseta sa iyo ng doktor?
Table in cardiovascular diseases
The main reasons for the development of cardiovascular diseases
Resorts Cardiovascular Diseases
Diseases of the cardiovascular-related
https://xn----ttbgni0a.xn--p1ai/articles/45567-cardiovascular-diseases-deaths-statistics.html
http://bux.webtm.ru/posts/96259-investigation-in-cardiovascular-diseases.html
Minsan lang na biglaang pagtaas ng presyon o bahagyang mataas na resulta ay hindi palaging nangangailangan ng agarang pag-inom ng tableta. Lahat ng rekomendasyon ng mga espesyalista at ang mga magagamit na paraan ng pag-iwas ay mukhang simple lang, pero sa aktwal na buhay, ang maingat na pag-aalaga sa kalusugan ng dugo at sistema ng puso ay nakakaiwas sa biglaan at sobrang hindi kanais-nais na pagtaas ng presyon. Ang mga modernong gamot sa pag-imprenta ay hinahati sa 10 iba't ibang grupo ayon sa kanilang mekanismo ng pagkilos. Pagkatapos suriin ng doktor ang mga reklamo ng pasyente at ang resulta ng mga pagsusuri, nagrereseta siya ng isa o higit pang gamot, na hindi dapat baguhin nang mag-isa. Ang mga gamot sa puso at daluyan ng dugo ay hindi kabilang sa mga puwedeng irekomenda sa kaibigan. Ang maling desisyon ay maaaring magdulot ng malungkot na kahihinatnan. Lahat ng gamot na pampababa ng presyon ng dugo ay kailangan ng reseta. Sa artikulong ito, tinitingnan natin ang kanilang modernong klasipikasyon base sa mga aktibong sangkap at sa paraan ng epekto nito sa katawan.
A drug against hypertension of the new-Generation Edgar — evaluation of the clinical data, and user reviews High blood pressure (arterial hypertension) remains one of the most important health challenges of the 21st century. Century. The development of new drugs that allow for the effective reduction of blood pressure and lower rate of side effects, is thus of high medical relevance. In this contribution, the new antihypertensive agent is introduced to Edgar, and on the Basis of the clinical studies, as well as user ratings rating. Pharmacological Properties Edgar belongs to the class of selective Angiotensin‑II‑receptor blocker (ARB). The drug acts by competitive inhibition of the Angiotensin II type 1 receptors (AT1 receptors), which leads to Vasodilatation and, consequently, to a reduction in peripheral vascular resistance. In comparison to the classical ACE inhibitors Edgar shows a lower incidence of side effects such as cough or angioedema. Clinical Studies In several randomized, double-blind studies to investigate the efficacy and tolerability of Edgar. A study of 1200 patients aged 45 to 75 years, showed that the daily administration of 80 mg of Edgar led to an average reduction in systolic blood pressure of 18.5 mmHg, and in diastolic blood pressure of 11.2 mmHg after 12 weeks. These values are comparable with those of well-established ARB drugs, but with a significantly better tolerability. The safety analysis showed that only 3.4% of the patients reported a slight headache, or fatigue, while severe side effects occurred in less than 0.5% of the cases. User reviews In order to assess the practical applicability of Edgar, were evaluated in addition, Online reviews of the patients. A total of 450 reviews were analyzed, which were published on various health platforms. The results showed: 87% of users rated the effectiveness of the drug as good or very good; 92% stated that they had to stop taking them due to side effects; 78% recommended the drug to other patients. Frequently mentioned advantages are the ease of dosing (once daily), the rapid onset of effect of time (within 2-3 days) and the low number of side effects were. Some patients, however, reported on a slight dizziness in the first days of therapy, which were, however, quickly. Discussion and conclusion The combined analysis of clinical data and user reviews shows that Edgar is a promising drug of the new Generation against high blood pressure. Its high efficacy, good tolerability, and ease of use make it an attractive Option in the long-term treatment of arterial hypertension. Further long-term studies are needed to assess the impact over a period of several years, and possible rare side effects to uncover. However, you can still find that Edgar can make a valuable contribution to the improvement of blood pressure control and quality of life of patients with hypertension.